Glutamate receptor GluR3 antibodies and death of cortical cells

Neuron

Volumn 20, Issue 1, 1998, Pages 153-163

  He, Xiao Ping ^a   Patel, Manisha ^a   Whitney, Karl D ^a,b   Janumpalli, Sridevi ^a   Tenner, Andrea ^c   McNamara, James O ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DURHAM VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE RECEPTOR; IMMUNOGLOBULIN G;

ANTIGEN BINDING; ARTICLE; AUTOIMMUNITY; CELL DEATH; DISEASE ASSOCIATION; ELECTROPHORESIS; EPILEPSY; HEMOLYSIS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEOCORTEX; PRIORITY JOURNAL; RASMUSSEN SYNDROME;

EID: 0031886287     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80443-2     Document Type: Article

References (26)

1. Abbas, A.K., Lichtman, A.H., and Pober, J.S. (1991). The complement system. In Cellular and Molecular Immunology (Philadelphia: W. B. Saunders), pp. 260-267.
2. Andrews, P.I., Dichter, M.A., Berkovic, S.F., Newton, M.R., and McNamara, J.O. (1996). Plasmapheresis in Rasmussen's encephalitis. Neurology 46, 242-246.
3. Brightman, M.W., Klatzo, I., Olsson, Y., and Reese, T.S. (1970). The blood-brain barrier to proteins under normal and pathological conditions. J. Neurol. Sci. 10, 215-239.
4. Choi, D.W. (1988). Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634.
5. Christadoss, P., Lindstrom, J., Munro, S., and Talal, N. (1985). Muscle acetycholine receptor loss in murine experimental autoimmune myasthenia gravis: correlated with cellular, humoral, and clinical responses. J. Neuroimmunol. 8, 29-41.
6. Drachman, D.B. (1994). Medical progress: myasthenia gravis. N. Eng. J. Med. 330, 1797-1810.
7. Engel, A.G., and Arahata, K. (1987). The membrane attack complex of complement at the endplate in myasthenia gravis. Ann. N. Y. Acad. Sci. 505, 326-332.
8. Engel, A.G., Sahashi, K., Lambert, E.H., and Howard, F.M. (1979). The ultrastructural localization of the acetylcholine receptor, immunoglobulin G and the third and ninth complement components at the motor end-plate and their implications for the pathogenesis of myasthenia gravis. In Current Topics in Nerve and Muscle Research, A.J. Aguayo and G. Karpati, eds. (Amsterdam: Excerpta Medica), pp. 111-122.
9. Eshhar, N., Petralia, R.S., Winters, C.A., Niedzielinski, A.S., and Wenthold, R.J. (1993). The segregation and expression of glutamate receptor subunits in cultured hippocampal neurons. Neuroscience 57, 943-964.
10. Fabian, R.H., and Ritchie, T.C. (1986). Intraneuronal IgG in the central nervous system. J. Neurol. Sci. 73, 257-267.
11. Farrell, M.A., Droogan, O., Secor, D.L., Poukens, V., Quinn, B., and Vinters, H.V. (1995). Chronic encephalitis associated with epilepsy: immunohistochemical and ultrastructural studies. Acta Neuropathol. 89, 313-321.
12. Harlow, E., and Lane, D. (1988) Reagents. In Antibodies (Cold Spring Harbor Laboratory), pp. 632-633.
13. Kabat, E.A., and Mayer, M.M. (1961). Complement and complement fixation. In Experimental Immunochemistry, E.A. Kabat and M.M. Mayer, eds. (Springfield, IL: Charles Thomas), pp. 133-240.
14. Keinanen, K., Wisden, W., Sommer, B., Werner, P., Herb, A., Verdoorn, T.A., Sakmann, B., and Seeburg, P.H. (1990). A family of AMPA-selective glutamate receptors. Science 249, 556-560.
15. Lerea, L.S., Butler, L.S., and McNamara, J.O. (1992). NMDA and non-NMDA receptor-mediated increase of c-fos mRNA in dentate gyrus neurons involves calcium influx via different routes. J. Neurosci. 12, 2973-2981.
16. McGeer, P.L., Akiyama, H., Itagaki, S., and McGeer, E.G. (1989). Immune system response in Alzheimer's disease. Can. J. Neurol. Sci. 16, 516-527.
17. Morgan, B.P. (1993). Complement in diseases of the nervous system. In Complement in Health and Disease, Second Edition, K. Whaley, M. Loos, and J.M. Weiler, eds. (Dordecht: Kluwer Academic Press), pp. 353-375.
18. Patel, M., Day, B.J., Crapo, J.D., Fridovich, I., and McNamara, J.O. (1996). Requirement for superoxide in excitotoxic cell death. Neuron 16, 345-355.
19. Rasmussen, T., and Andermann, F. (1989). Update on the syndrome of "chronic encephalitis" and epilepsy. Cleve. Clin. J. Med. 56 (suppl.), 81-84.
20. Rasmussen, T., Olszewski, J., Lloyd-Smith, D.K. (1958). Focal seizures due to chronic localized encephalitis. Neurology 8, 435-455.
21. Rogers, S.W., Andrews, P.I., Gahring, L.C., Whisenand, T., Cauley, K., Crain, B., Hughes, T.E., Heinemann, S.F., and McNamara, J.O. (1994). Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 265, 648-651.
22. Schmidt-Kastner, R., Meller, D., Bellander, B.M., Stromberg, I., Olson, L., and Ingvar, M. (1993). A one-step immunohistochemical method for detection of blood-brain barrier disurbances for immunoglobulins in lesioned rat brain with special reference to false-positive labeling in immunohistochemistry. J. Neurosci. Methods 46, 121-132.
23. Twyman, R.E., Gahring, L.C., Spiess, J., and Rogers, S.W. (1995). Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site. Neuron 14, 755-762.
24. Vassault, A. (1983). Lactate dehydrogenase. In Methods of Enzymatic Analysis, H.U. Bergmeyer, ed. (Weinheim: Verlag Chemie), pp. 188-126.
25. Weisman, H.F., Bartow, T., Leppo, M.K., Marsh, H.C., Carson, G.R., Concino, M.F., Boyle, M.P., Roux, K.H., Weisfeldt, M.L., and Fearon, D.T. (1990). Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 249, 146-151.
26. Wenthold, R.J., Petralia, R.S., Blahos, J., II, and Niedzielski, A.S. (1996). Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J. Neurosci. 16, 1982-1989.